Physician

Joshua Samuel Jacobs, MD

According to 2025 Medicare claims, Joshua Jacobs, MD (NPI: 1215920673) practices allergy/immunology in the Oakland-Fremont-Berkeley, CA market, with the plurality of this provider's patient population coming from Contra Costa, CA. This provider's primary affiliated billing organization is ALLERGY & ASTHMA MEDICAL GROUP OF THE BAY AREA INC (NPI: 1871550590; TIN: 94-2437825) and primary practice location at 94598-2452.

Jacobs' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 335 traditional Medicare patients, billed 70,779 HCPCS/CPT codes, and received $1,541,879 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,745 prescription claims across 285 beneficiaries totaling $6,415,411 in drug costs, led by Haegarda (C1 Esterase Inhibitor). DME data shows 244 claims. Open Payments data shows 430 records totaling $647,868. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $272,028 to $1,541,879. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,332,892 to $6,415,411. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $4,901 and ending at $7,217.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	245	12,196	$272,028
2016	253	12,060	$400,514
2017	246	25,961	$519,533
2018	281	28,592	$781,521
2019	317	39,512	$948,327
2020	285	39,039	$862,060
2021	297	38,488	$876,175
2022	296	43,048	$1,147,761
2023	299	56,231	$1,257,482
2024	335	70,779	$1,541,879

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	212	1,357	$2,332,892
2016	208	1,427	$2,699,463
2017	196	1,339	$2,905,930
2018	217	1,429	$2,965,367
2019	224	1,359	$2,900,612
2020	230	1,636	$3,683,893
2021	269	1,776	$4,185,730
2022	273	1,855	$5,270,410
2023	265	1,768	$6,929,907
2024	285	1,745	$6,415,411

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	27	160	$97,497
2016	24	220	$193,722
2017	N/R	146	$189,794
2018	N/R	160	$132,300
2019	12	208	$154,618
2020	13	309	$286,583
2021	N/R	353	$355,330
2022	N/R	303	$363,796
2023	11	279	$371,911
2024	13	244	$347,736

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	258	529	$112
94010	Test to measure expiratory airflow and volume	118	186	$27
95012	Test to measure the level of nitric oxide gas	144	231	$20
96372	Injection of drug or substance under skin or into muscle	63	566	$14
96160	Administration and interpretation of patient-focused health risk assessment	137	228	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Haegarda	C1 Esterase Inhibitor	42	1,188	$1,925,416
Takhzyro	Lanadelumab-Flyo	33	924	$1,401,893
Icatibant	Icatibant Acetate	23	229	$1,013,486
Firazyr	Icatibant Acetate	11	316	$923,782
Dupixent Syringe	Dupilumab	67	2,184	$272,979

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	64	$286,493
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	13	$52,893
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	67	$5,154
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	13	25	$1,870
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	75	$1,327

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	382	$248,422	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	47	$399,446	CSL Behring
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$4,891	Consortium of Independent Immunology Clinics, LLC

Explore More Providers

FAQ

What Medicare data is available for Joshua Samuel Jacobs, MD?

Tedicare shows public-source Medicare data for Joshua Samuel Jacobs, MD (NPI 1215920673), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joshua Samuel Jacobs, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Joshua Samuel Jacobs, MD?

Joshua Samuel Jacobs, MD is linked to ALLERGY & ASTHMA MEDICAL GROUP OF THE BAY AREA INC (billing NPI 1871550590) in the available physician profile data.

Does Joshua Samuel Jacobs, MD have Open Payments data?

Joshua Samuel Jacobs, MD has 430 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.